Emmaus Life Sciences, Inc. Quarterly report [Sections 13 or 15(d)]

Quarterly report [Sections 13 or 15(d)]

Notes Payable - Additional Information (Details)

Notes Payable - Additional Information (Details)		1 Months Ended											2 Months Ended	3 Months Ended		12 Months Ended
Notes Payable - Additional Information (Details)	Feb. 09, 2021 USD ($) $ / shares	Feb. 28, 2026 USD ($)	Dec. 31, 2025 USD ($)	Oct. 31, 2025 USD ($)	Sep. 30, 2025 USD ($)	Aug. 31, 2025 USD ($)	Jun. 30, 2025 USD ($)	May 31, 2025 USD ($)	Feb. 28, 2025 USD ($)	Dec. 31, 2024 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($) $ / shares	Mar. 31, 2024 USD ($) $ / shares	Mar. 31, 2026 USD ($) $ / shares	Mar. 31, 2025 USD ($)	Dec. 31, 2025 USD ($) shares	May 31, 2024	Feb. 29, 2024 USD ($)
Debt Instrument [Line Items]
Weighted-average stated annual interest rate			15.00%											14.00%		15.00%
Weighted-average effective annual interest rate			18.00%											16.00%		18.00%
Principal Amount Outstanding			$ 27,128,000											$ 26,558,000		$ 27,128,000
Gain (loss) on debt extinguishment														(76,000)	$ (164,000)
Term of Notes		210 days
Fair value of the conversion feature														0
Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Conversion price \| $ / shares													$ 0.13
Interest rate													10.00%
Demand Promissory Notes [Member]
Debt Instrument [Line Items]
Principal amount																		$ 2,800,000
Wei Pei Zen [Member] \| Smart Start Investments Limited [Member]
Debt Instrument [Line Items]
Principal amount													$ 1,400,000
Interest rate													2.50%
Default percentage of interest rate																	0.05
Wei Pei Zen [Member] \| Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Principal amount												$ 1,000,000
Conversion price \| $ / shares												$ 0.29
Interest rate												10.00%
Debt instrument, maturity date												Sep. 05, 2024
Securities Purchase Agreement [Member] \| Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Principal amount	$ 14,500,000		2,400,000											$ 8,600,000		$ 2,400,000
Conversion price \| $ / shares	$ 1.48													$ 0.01
Debt instrument, frequency of periodic payment	The convertible promissory notes bear interest at the rate of 2% per year (10% in case of default), payable semi-annually on the last business day of August and January of each year and matured on the 3rd anniversary of the original issue date.
Interest rate	2.00%
Amount of principal repaid														$ 9,000,000	$ 150,000,000
Convertible notes converted to shares (in shares) \| shares																6,322,692
Fair valued of equity recognized			72,000,000													$ 72,000,000
Deferred recognizing gain on restructured debt																$ 2,400,000
Interest rate on default payment	10.00%
Revenue Purchase Agreement [Member]
Debt Instrument [Line Items]
Principal amount					$ 141,000
Outstanding balance of the loans														900,000
Outstanding balance repaid				$ 600,000		$ 600,000		$ 400,000	$ 300,000
Installment payment					11,000
Gain (loss) on debt extinguishment						300,000		200,000	200,000
Sale of accounts receivable		$ 1,700,000						2,100,000	1,900,000	$ 1,500,000	$ 1,300,000
Proceeds from sale of notes receivable		1,100,000						1,500,000	1,300,000	900,000	800,000
Amount agreed to pay weekly sales receipts		$ 57,000,000						62,000,000	49,000,000	$ 43,000,000	$ 35,000,000
Term of Notes											70 days
Amount agreed to pay weekly sales receipts thereafter until future receipt is delivered											$ 41,000,000
Origination fees								$ 100,000	$ 100,000
Financial charge					$ 65,000,000
Future Receivables Sale and Purchase Agreement [Member]
Debt Instrument [Line Items]
Installment payment				300,000
Sale of accounts receivable							$ 1,000,000
Proceeds from sale of notes receivable							800,000
Amount agreed to pay weekly sales receipts							51,000,000
Origination fees							$ 38,000,000
Revenue Purchase Agreement [Member]
Debt Instrument [Line Items]
Outstanding balance repaid				1,200,000
Sale of accounts receivable						1,900,000
Proceeds from sale of notes receivable						1,200,000
Amount agreed to pay weekly sales receipts						59,000,000
Origination fees						100,000
October One Revenue Purchase Agreement [Member]
Debt Instrument [Line Items]
Sale of accounts receivable				900,000
Proceeds from sale of notes receivable				600,000
Amount agreed to pay weekly sales receipts				52,000,000
Origination fees				34,000,000
October Revenue Purchase Agreement [Member]
Debt Instrument [Line Items]
Outstanding balance of the loans														$ 1,000,000
Gain (loss) on debt extinguishment						$ 600,000
Sale of accounts receivable				3,600,000
Proceeds from sale of notes receivable				2,300,000
Amount agreed to pay weekly sales receipts				94,000,000
Origination fees				$ 300,000
December Revenue Purchase Agreement [Member]
Debt Instrument [Line Items]
Sale of accounts receivable			800,000
Proceeds from sale of notes receivable			500,000
Amount agreed to pay weekly sales receipts			54,000,000
Origination fees			$ 45,000,000
Exchange Agreement [Member] \| Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Principal amount													$ 11,100,000
Maturity year													2024
Conversion price \| $ / shares													$ 0.13
Interest rate													2.00%